Literature DB >> 31482412

Clinical Applications for Radiotracer Imaging of Lower Extremity Peripheral Arterial Disease and Critical Limb Ischemia.

Ting-Heng Chou1, Mitchel R Stacy2,3.   

Abstract

Peripheral arterial disease (PAD) is an atherosclerotic occlusive disease of the non-coronary vessels that is characterized by lower extremity tissue ischemia, claudication, increased prevalence of lower extremity wounds and amputations, and impaired quality of life. Critical limb ischemia (CLI) represents the severe stage of PAD and is associated with additional risk for wound formation, amputation, and premature death. Standard clinical tools utilized for assessing PAD and CLI primarily focus on anatomical evaluation of peripheral vascular lesions or hemodynamic assessment of the peripheral circulation. Evaluation of underlying pathophysiology has traditionally been achieved by radiotracer-based imaging, with many clinical investigations focusing on imaging of skeletal muscle perfusion and cases of foot infection/inflammation such as osteomyelitis and Charcot neuropathic osteoarthropathy. As advancements in hybrid imaging systems and radiotracers continue to evolve, opportunities for molecular imaging of PAD and CLI are also emerging that may offer novel insight into associated complications such as peripheral atherosclerosis, alterations in skeletal muscle metabolism, and peripheral neuropathy. This review summarizes the pros and cons of radiotracer-based techniques that have been utilized in the clinical environment for evaluating lower extremity ischemia and common pathologies associated with PAD and CLI.

Entities:  

Keywords:  Critical limb ischemia; Peripheral arterial disease; Positron emission tomography; Radiotracer imaging; Single-photon emission computed tomography

Mesh:

Substances:

Year:  2020        PMID: 31482412      PMCID: PMC7580768          DOI: 10.1007/s11307-019-01425-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  101 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources.

Authors:  Sherif Heiba; Dov Kolker; Leonard Ong; Shalini Sharma; Arlene Travis; Victoria Teodorescu; Sharif Ellozy; Lale Kostakoglu; Ina Savitch; Josef Machac
Journal:  Nucl Med Commun       Date:  2013-09       Impact factor: 1.690

3.  Preamputation evaluation of lower-limb skeletal muscle perfusion with H(2) (15)O positron emission tomography.

Authors:  Oscar U Scremin; Stephen F Figoni; Keith Norman; A M Erika Scremin; Charles F Kunkel; Dorene Opava-Rutter; Eric D Schmitter; Alberto Bert; Mark Mandelkern
Journal:  Am J Phys Med Rehabil       Date:  2010-06       Impact factor: 2.159

4.  New method for studying peripheral circulation in man.

Authors:  E L Jones; H N Wagner; G D Zuidema
Journal:  Arch Surg       Date:  1965-11

5.  Local sympathetic denervation in painful diabetic neuropathy.

Authors:  Cees J Tack; Petra J van Gurp; Courtney Holmes; David S Goldstein
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

6.  Application of white blood cell SPECT/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis.

Authors:  Julien Vouillarmet; Myriam Moret; Isabelle Morelec; Paul Michon; Julien Dubreuil
Journal:  Diabetologia       Date:  2017-09-02       Impact factor: 10.122

7.  Diabetic foot infections: scintigraphic evaluation with 99Tcm-labelled anti-granulocyte antibodies.

Authors:  L Dominguez-Gadea; L M Martin-Curto; H de la Calle; A Crespo
Journal:  Nucl Med Commun       Date:  1993-03       Impact factor: 1.690

8.  Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?

Authors:  Sandip Basu; Timothy Chryssikos; Mohamed Houseni; D Scot Malay; Jagruti Shah; Hongming Zhuang; Abass Alavi
Journal:  Nucl Med Commun       Date:  2007-06       Impact factor: 1.690

Review 9.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

Review 10.  Charcot foot in diabetes and an update on imaging.

Authors:  Fatma Bilge Ergen; Saziye Eser Sanverdi; Ali Oznur
Journal:  Diabet Foot Ankle       Date:  2013-11-20
View more
  4 in total

Review 1.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

2.  Molecular Imaging of Lower Extremity Peripheral Arterial Disease: An Emerging Field in Nuclear Medicine.

Authors:  Mitchel R Stacy
Journal:  Front Med (Lausanne)       Date:  2022-01-12

3.  Evaluation of Hyperspectral Imaging for Follow-Up Assessment after Revascularization in Peripheral Artery Disease.

Authors:  Eberhard Grambow; Niels Arne Sandkühler; Justus Groß; Daniel G E Thiem; Michael Dau; Matthias Leuchter; Malte Weinrich
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

4.  Novel Application of 18F-NaF PET/CT Imaging for Evaluation of Active Bone Remodeling in Diabetic Patients With Charcot Neuropathy: A Proof-of-Concept Report.

Authors:  Nguyen K Tram; Ting-Heng Chou; Surina Patel; Laila N Ettefagh; Michael R Go; Said A Atway; Mitchel R Stacy
Journal:  Front Med (Lausanne)       Date:  2022-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.